v3.25.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities    
Net loss $ (177) $ (588)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 189 1
Share based payment 398 35
Fair value revaluation of investment in shares 8
Fair value revaluation of warrant liability (5,218) 211
Fair value revaluation in convertible notes 25
Finance expenses 3,059
Change in:    
Other current assets (105) (7)
Deferred offering costs (39)
Employees and payroll-related liabilities (16)
Othrer payables and accrued expenses 33 33
Net cash used in operating activities (1,821) (337)
Cash flows from investing activities    
Purchase of property and equipment (2)
Net cash used in investing activities (2)
Cash flows from financing activities    
Proceeds from sale of investment in shares 28
Proceeds from issuance of convertible notes 151
Proceeds from issuance of ordinary shares, warrants and pre-funded warrants 15,097 177
Net cash provided by financing activities 15,097 356
Change in cash and cash equivalents 13,274 19
Cash and cash equivalents at the beginning of the year 2,554 4
Cash and cash equivalents at the end of the year 15,828 23
Non-cash financing activities:    
Exercise of warrants into ordinary shares 11,100
IPO warrants exchange 1,635
Conversion of convertible notes into ordinary shares 225
Classification of warrant liability into Additional paid-in capital $ 316